The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Artificial Intelligence-driven Drug Development Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Global Artificial Intelligence-driven Drug Development Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1749412

No of Pages : 123

Ask Your Query

Synopsis
The global Artificial Intelligence-driven Drug Development market size was valued at USD 1405.9 million in 2022 and is forecast to a readjusted size of USD 8513.8 million by 2029 with a CAGR of 29.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Artificial intelligence (AI) has the potential to revolutionize the drug discovery process,
offering improved efficiency, accuracy, and speed.

This report is a detailed and comprehensive analysis for global Artificial Intelligence-driven Drug Development market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

  • Global Artificial Intelligence-driven Drug Development market size and forecasts, in consumption value ($ Million), 2018-2029
  • Global Artificial Intelligence-driven Drug Development market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
  • Global Artificial Intelligence-driven Drug Development market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
  • Global Artificial Intelligence-driven Drug Development market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Artificial Intelligence-driven Drug Development
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace

This report profiles key players in the global Artificial Intelligence-driven Drug Development market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IBM, Exscientia, Google(Alphabet), Microsoft and Atomwise, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Artificial Intelligence-driven Drug Development market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Hardware
  • Software
  • Service

Market segment by Application

  • Early Drug Discovery
  • Preclinical Phase
  • Clinical Phase
  • Regulatory Approval

Market segment by players, this report covers

  • IBM
  • Exscientia
  • Google(Alphabet)
  • Microsoft
  • Atomwise
  • Schrodinger
  • Aitia
  • Insilico Medicine
  • NVIDIA
  • XtalPi
  • BPGbio
  • Owkin
  • CytoReason
  • Deep Genomics
  • Cloud Pharmaceuticals
  • BenevolentAI
  • Cyclica
  • Verge Genomics
  • Valo Health
  • Envisagenics
  • Euretos
  • BioAge Labs
  • Iktos
  • BioSymetrics
  • Evaxion Biotech
  • Aria Pharmaceuticals

Market segment by regions, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Artificial Intelligence-driven Drug Development product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Artificial Intelligence-driven Drug Development, with revenue, gross margin and global market share of Artificial Intelligence-driven Drug Development from 2018 to 2023.
Chapter 3, the Artificial Intelligence-driven Drug Development competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Artificial Intelligence-driven Drug Development market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Intelligence-driven Drug Development.
Chapter 13, to describe Artificial Intelligence-driven Drug Development research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Artificial Intelligence-driven Drug Development
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Artificial Intelligence-driven Drug Development by Type
1.3.1 Overview: Global Artificial Intelligence-driven Drug Development Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Artificial Intelligence-driven Drug Development Consumption Value Market Share by Type in 2022
1.3.3 Hardware
1.3.4 Software
1.3.5 Service
1.4 Global Artificial Intelligence-driven Drug Development Market by Application
1.4.1 Overview: Global Artificial Intelligence-driven Drug Development Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Early Drug Discovery
1.4.3 Preclinical Phase
1.4.4 Clinical Phase
1.4.5 Regulatory Approval
1.5 Global Artificial Intelligence-driven Drug Development Market Size & Forecast
1.6 Global Artificial Intelligence-driven Drug Development Market Size and Forecast by Region
1.6.1 Global Artificial Intelligence-driven Drug Development Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Artificial Intelligence-driven Drug Development Market Size by Region, (2018-2029)
1.6.3 North America Artificial Intelligence-driven Drug Development Market Size and Prospect (2018-2029)
1.6.4 Europe Artificial Intelligence-driven Drug Development Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Artificial Intelligence-driven Drug Development Market Size and Prospect (2018-2029)
1.6.6 South America Artificial Intelligence-driven Drug Development Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Artificial Intelligence-driven Drug Development Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 IBM
2.1.1 IBM Details
2.1.2 IBM Major Business
2.1.3 IBM Artificial Intelligence-driven Drug Development Product and Solutions
2.1.4 IBM Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 IBM Recent Developments and Future Plans
2.2 Exscientia
2.2.1 Exscientia Details
2.2.2 Exscientia Major Business
2.2.3 Exscientia Artificial Intelligence-driven Drug Development Product and Solutions
2.2.4 Exscientia Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Exscientia Recent Developments and Future Plans
2.3 Google(Alphabet)
2.3.1 Google(Alphabet) Details
2.3.2 Google(Alphabet) Major Business
2.3.3 Google(Alphabet) Artificial Intelligence-driven Drug Development Product and Solutions
2.3.4 Google(Alphabet) Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Google(Alphabet) Recent Developments and Future Plans
2.4 Microsoft
2.4.1 Microsoft Details
2.4.2 Microsoft Major Business
2.4.3 Microsoft Artificial Intelligence-driven Drug Development Product and Solutions
2.4.4 Microsoft Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Microsoft Recent Developments and Future Plans
2.5 Atomwise
2.5.1 Atomwise Details
2.5.2 Atomwise Major Business
2.5.3 Atomwise Artificial Intelligence-driven Drug Development Product and Solutions
2.5.4 Atomwise Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Atomwise Recent Developments and Future Plans
2.6 Schrodinger
2.6.1 Schrodinger Details
2.6.2 Schrodinger Major Business
2.6.3 Schrodinger Artificial Intelligence-driven Drug Development Product and Solutions
2.6.4 Schrodinger Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Schrodinger Recent Developments and Future Plans
2.7 Aitia
2.7.1 Aitia Details
2.7.2 Aitia Major Business
2.7.3 Aitia Artificial Intelligence-driven Drug Development Product and Solutions
2.7.4 Aitia Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Aitia Recent Developments and Future Plans
2.8 Insilico Medicine
2.8.1 Insilico Medicine Details
2.8.2 Insilico Medicine Major Business
2.8.3 Insilico Medicine Artificial Intelligence-driven Drug Development Product and Solutions
2.8.4 Insilico Medicine Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Insilico Medicine Recent Developments and Future Plans
2.9 NVIDIA
2.9.1 NVIDIA Details
2.9.2 NVIDIA Major Business
2.9.3 NVIDIA Artificial Intelligence-driven Drug Development Product and Solutions
2.9.4 NVIDIA Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 NVIDIA Recent Developments and Future Plans
2.10 XtalPi
2.10.1 XtalPi Details
2.10.2 XtalPi Major Business
2.10.3 XtalPi Artificial Intelligence-driven Drug Development Product and Solutions
2.10.4 XtalPi Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 XtalPi Recent Developments and Future Plans
2.11 BPGbio
2.11.1 BPGbio Details
2.11.2 BPGbio Major Business
2.11.3 BPGbio Artificial Intelligence-driven Drug Development Product and Solutions
2.11.4 BPGbio Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BPGbio Recent Developments and Future Plans
2.12 Owkin
2.12.1 Owkin Details
2.12.2 Owkin Major Business
2.12.3 Owkin Artificial Intelligence-driven Drug Development Product and Solutions
2.12.4 Owkin Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Owkin Recent Developments and Future Plans
2.13 CytoReason
2.13.1 CytoReason Details
2.13.2 CytoReason Major Business
2.13.3 CytoReason Artificial Intelligence-driven Drug Development Product and Solutions
2.13.4 CytoReason Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 CytoReason Recent Developments and Future Plans
2.14 Deep Genomics
2.14.1 Deep Genomics Details
2.14.2 Deep Genomics Major Business
2.14.3 Deep Genomics Artificial Intelligence-driven Drug Development Product and Solutions
2.14.4 Deep Genomics Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Deep Genomics Recent Developments and Future Plans
2.15 Cloud Pharmaceuticals
2.15.1 Cloud Pharmaceuticals Details
2.15.2 Cloud Pharmaceuticals Major Business
2.15.3 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Product and Solutions
2.15.4 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Cloud Pharmaceuticals Recent Developments and Future Plans
2.16 BenevolentAI
2.16.1 BenevolentAI Details
2.16.2 BenevolentAI Major Business
2.16.3 BenevolentAI Artificial Intelligence-driven Drug Development Product and Solutions
2.16.4 BenevolentAI Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 BenevolentAI Recent Developments and Future Plans
2.17 Cyclica
2.17.1 Cyclica Details
2.17.2 Cyclica Major Business
2.17.3 Cyclica Artificial Intelligence-driven Drug Development Product and Solutions
2.17.4 Cyclica Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Cyclica Recent Developments and Future Plans
2.18 Verge Genomics
2.18.1 Verge Genomics Details
2.18.2 Verge Genomics Major Business
2.18.3 Verge Genomics Artificial Intelligence-driven Drug Development Product and Solutions
2.18.4 Verge Genomics Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Verge Genomics Recent Developments and Future Plans
2.19 Valo Health
2.19.1 Valo Health Details
2.19.2 Valo Health Major Business
2.19.3 Valo Health Artificial Intelligence-driven Drug Development Product and Solutions
2.19.4 Valo Health Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Valo Health Recent Developments and Future Plans
2.20 Envisagenics
2.20.1 Envisagenics Details
2.20.2 Envisagenics Major Business
2.20.3 Envisagenics Artificial Intelligence-driven Drug Development Product and Solutions
2.20.4 Envisagenics Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Envisagenics Recent Developments and Future Plans
2.21 Euretos
2.21.1 Euretos Details
2.21.2 Euretos Major Business
2.21.3 Euretos Artificial Intelligence-driven Drug Development Product and Solutions
2.21.4 Euretos Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Euretos Recent Developments and Future Plans
2.22 BioAge Labs
2.22.1 BioAge Labs Details
2.22.2 BioAge Labs Major Business
2.22.3 BioAge Labs Artificial Intelligence-driven Drug Development Product and Solutions
2.22.4 BioAge Labs Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 BioAge Labs Recent Developments and Future Plans
2.23 Iktos
2.23.1 Iktos Details
2.23.2 Iktos Major Business
2.23.3 Iktos Artificial Intelligence-driven Drug Development Product and Solutions
2.23.4 Iktos Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Iktos Recent Developments and Future Plans
2.24 BioSymetrics
2.24.1 BioSymetrics Details
2.24.2 BioSymetrics Major Business
2.24.3 BioSymetrics Artificial Intelligence-driven Drug Development Product and Solutions
2.24.4 BioSymetrics Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 BioSymetrics Recent Developments and Future Plans
2.25 Evaxion Biotech
2.25.1 Evaxion Biotech Details
2.25.2 Evaxion Biotech Major Business
2.25.3 Evaxion Biotech Artificial Intelligence-driven Drug Development Product and Solutions
2.25.4 Evaxion Biotech Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Evaxion Biotech Recent Developments and Future Plans
2.26 Aria Pharmaceuticals
2.26.1 Aria Pharmaceuticals Details
2.26.2 Aria Pharmaceuticals Major Business
2.26.3 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Product and Solutions
2.26.4 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.26.5 Aria Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Artificial Intelligence-driven Drug Development Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Artificial Intelligence-driven Drug Development by Company Revenue
3.2.2 Top 3 Artificial Intelligence-driven Drug Development Players Market Share in 2022
3.2.3 Top 6 Artificial Intelligence-driven Drug Development Players Market Share in 2022
3.3 Artificial Intelligence-driven Drug Development Market: Overall Company Footprint Analysis
3.3.1 Artificial Intelligence-driven Drug Development Market: Region Footprint
3.3.2 Artificial Intelligence-driven Drug Development Market: Company Product Type Footprint
3.3.3 Artificial Intelligence-driven Drug Development Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Artificial Intelligence-driven Drug Development Consumption Value and Market Share by Type (2018-2023)
4.2 Global Artificial Intelligence-driven Drug Development Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Artificial Intelligence-driven Drug Development Consumption Value Market Share by Application (2018-2023)
5.2 Global Artificial Intelligence-driven Drug Development Market Forecast by Application (2024-2029)
6 North America
6.1 North America Artificial Intelligence-driven Drug Development Consumption Value by Type (2018-2029)
6.2 North America Artificial Intelligence-driven Drug Development Consumption Value by Application (2018-2029)
6.3 North America Artificial Intelligence-driven Drug Development Market Size by Country
6.3.1 North America Artificial Intelligence-driven Drug Development Consumption Value by Country (2018-2029)
6.3.2 United States Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
6.3.3 Canada Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
6.3.4 Mexico Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Artificial Intelligence-driven Drug Development Consumption Value by Type (2018-2029)
7.2 Europe Artificial Intelligence-driven Drug Development Consumption Value by Application (2018-2029)
7.3 Europe Artificial Intelligence-driven Drug Development Market Size by Country
7.3.1 Europe Artificial Intelligence-driven Drug Development Consumption Value by Country (2018-2029)
7.3.2 Germany Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
7.3.3 France Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
7.3.5 Russia Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
7.3.6 Italy Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence-driven Drug Development Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Artificial Intelligence-driven Drug Development Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Artificial Intelligence-driven Drug Development Market Size by Region
8.3.1 Asia-Pacific Artificial Intelligence-driven Drug Development Consumption Value by Region (2018-2029)
8.3.2 China Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
8.3.3 Japan Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
8.3.4 South Korea Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
8.3.5 India Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
8.3.7 Australia Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
9 South America
9.1 South America Artificial Intelligence-driven Drug Development Consumption Value by Type (2018-2029)
9.2 South America Artificial Intelligence-driven Drug Development Consumption Value by Application (2018-2029)
9.3 South America Artificial Intelligence-driven Drug Development Market Size by Country
9.3.1 South America Artificial Intelligence-driven Drug Development Consumption Value by Country (2018-2029)
9.3.2 Brazil Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
9.3.3 Argentina Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence-driven Drug Development Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Artificial Intelligence-driven Drug Development Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Country
10.3.1 Middle East & Africa Artificial Intelligence-driven Drug Development Consumption Value by Country (2018-2029)
10.3.2 Turkey Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
10.3.4 UAE Artificial Intelligence-driven Drug Development Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Artificial Intelligence-driven Drug Development Market Drivers
11.2 Artificial Intelligence-driven Drug Development Market Restraints
11.3 Artificial Intelligence-driven Drug Development Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Artificial Intelligence-driven Drug Development Industry Chain
12.2 Artificial Intelligence-driven Drug Development Upstream Analysis
12.3 Artificial Intelligence-driven Drug Development Midstream Analysis
12.4 Artificial Intelligence-driven Drug Development Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock